SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-114247
Filing Date
2022-11-03
Accepted
2022-11-03 09:06:55
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 tm2229282-1_s3.htm S-3 561084
2 EXHIBIT 1.2 tm2229282d2_ex1-2.htm EX-1.2 263675
3 EXHIBIT 4.5 tm2229282d2_ex4-5.htm EX-4.5 309304
4 EXHIBIT 4.6 tm2229282d2_ex4-6.htm EX-4.6 315915
5 EXHIBIT 5.1 tm2229282d2_ex5-1.htm EX-5.1 18296
6 EXHIBIT 5.2 tm2229282d2_ex5-2.htm EX-5.2 10714
7 EXHIBIT 23.1 tm2229282d2_ex23-1.htm EX-23.1 2068
8 EX-FILING FEES tm2229282d2_ex-filingfees.htm EX-FILING FEES 39390
9 GRAPHIC lg_theseus-4clr.jpg GRAPHIC 18742
10 GRAPHIC lg_cantor-4c.jpg GRAPHIC 20412
11 GRAPHIC tm2229282d2_ex5-1img001.jpg GRAPHIC 8972
12 GRAPHIC tm2229282d2_ex5-2img001.jpg GRAPHIC 8972
  Complete submission text file 0001104659-22-114247.txt   1600680
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268125 | Film No.: 221356466
SIC: 2834 Pharmaceutical Preparations